Department of Infectious Disease Control, Beijing Institute of Disease Control and Prevention, No. 20, Dongdajie, Fengtai District, Beijing 100071, People's Republic of China.
Eur J Clin Microbiol Infect Dis. 2013 Mar;32(3):437-47. doi: 10.1007/s10096-012-1767-7. Epub 2012 Nov 15.
Brucellosis is an important zoonotic disease caused primarily by the bacterial pathogens Brucella melitensis and B. abortus. The pathogens cause debilitating febrile illness that can progress into a long-lasting disease with severe complications in humans. Understanding the mechanisms by which the host immune system responds to the infection will provide important information on the pathogenesis and development of differential diagnostic assays. In this study, a protein microarray was used to evaluate the antibody responses of brucellosis patients at different infection stages. A total of 107 outer membrane proteins, surface-exposed or secreted proteins, and known or putative virulence-associated proteins of B. melitensis were successfully expressed in Escherichia coli and used to fabricate the protein microarray. Then, 99 serum samples from acute, chronic, primary infection, or relapse brucellosis patients were probed with the protein microarray. Antibodies to 66 of the proteins were detected at least in one serum sample. Among the antigens, the combination of BMEII0318, BMEII0513, BMEI0748, and BMEII1116 could be used as serodiagnostic antigens for brucellosis. Patients at different infection stages show distinct antibody profiles. The numbers of antibodies in the relapse patients were superior to those in the primary infection patients, and the response magnitude of antibodies in the chronic infection patients was higher than those in the acute brucellosis patients. The sustained and differential antibody profiles of patients at different infection stages have implications for the development of new serological methods for the accurate diagnosis of human brucellosis, and contribute to a more detailed understanding of the pathogenesis of chronic brucellosis.
布鲁氏菌病是一种重要的人畜共患疾病,主要由细菌病原体布鲁氏菌和布鲁氏菌引起。病原体引起使人衰弱的发热疾病,可发展为慢性疾病,并在人类中引发严重并发症。了解宿主免疫系统对感染的反应机制将为了解发病机制和开发差异诊断检测提供重要信息。在这项研究中,使用蛋白质微阵列评估了不同感染阶段布鲁氏菌病患者的抗体反应。成功地在大肠杆菌中表达了 107 种外膜蛋白、表面暴露或分泌蛋白以及已知或推测的与毒力相关的布鲁氏菌属蛋白,并用于制造蛋白质微阵列。然后,用蛋白质微阵列探测了 99 份来自急性、慢性、原发性感染或复发布鲁氏菌病患者的血清样本。至少在一个血清样本中检测到针对 66 种蛋白质的抗体。在这些抗原中,BMEII0318、BMEII0513、BMEI0748 和 BMEII1116 的组合可用作布鲁氏菌病的血清学诊断抗原。处于不同感染阶段的患者表现出不同的抗体谱。复发患者的抗体数量优于原发性感染患者,慢性感染患者的抗体反应幅度高于急性布鲁氏菌病患者。不同感染阶段患者持续和差异的抗体谱对开发用于准确诊断人类布鲁氏菌病的新血清学方法具有重要意义,并有助于更详细地了解慢性布鲁氏菌病的发病机制。